Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
(2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine is an experimental small molecule belonging to the diphenylmethane class. It has been studied as a bioactive compound with potential biological activities and is referenced in chemical and drug databases as DB07857. The compound has not been approved for any medical use and there are no reported clinical trials beyond preclinical or early research phases. Its mechanism of action may involve inhibition of cAMP-dependent protein kinase catalytic subunit alpha, but pharmacological activity remains largely uncharacterized[1][7].
- Other names
- 2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamineBenzeneethanamine, beta-(4-chlorophenyl)-4-(1H-pyrazol-4-yl)-, (betaR)(2S)-2-(4-Chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine
02
Targets
PRKACB (cAMP-dependent protein kinase catalytic subunit beta)PKA (Cyclic amp-dependent protein kinase)
Beyond the preview
Go deeper on (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine.